2012

The I.M. Rosenzweig Junior Investigator Award Winners​

The I.M. Rosenzweig Junior Investigator Award was established to encourage researchers to maintain and enhance their interest in PF research during the early stages of their academic career. 

Glenn Rosen, MD

Apr 20, 2021, 12:57 PM
Title : Glenn Rosen, MD
First Name : Glenn
Middle Name :
Last Name : Rosen
Position :
University : Stanford University
Proposal Title : "Analysis of Novel Functions of Human Telomerase RNA in IPF"
Proposal Funder :
Dr. Rosen has been on the faculty of the Stanford University School of Medicine since 1993. He is presently an Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine. Dr. Rosen’s laboratory research focuses on translational studies in pulmonary fibrosis; specifically, his laboratory studies mechanisms involved in the pathogenesis of pulmonary fibrosis, and then applies the application of these discoveries to the development of novel treatments for fibrotic lung disease. Recent work in his laboratory has revealed novel functions of telomerase in pulmonary fibrosis and additional studies are focused on the genetics of pulmonary fibrosis. He has published broadly, he is active in clinical trials in idiopathic pulmonary fibrosis and works with biotechnology companies in the development of novel anti-fibrotic therapeutics. Dr. Rosen is the Clinical Director of the Stanford Interstitial Lung Disease Program at the Center for Advanced Lung Disease. Dr. Rosen’s active clinical and research program in interstitial lung disease gives him insight into how to apply basic research discoveries to help patients with advanced lung disease.
Load more comments
Comment by from

The Albert Rose Established Investigator Award Winners

Created to allow established investigators to explore novel, innovative areas of research, the Albert Rose Established Investigator Award provides critical support to the development of new projects, and enables the investigator to pursue additional funding through the National Institutes of Health or other agencies. Two $50,000 grants are awarded per annual cycle, disbursed over a two-year period.

Glenn Rosen, MD

Apr 20, 2021, 12:57 PM
Title : Glenn Rosen, MD
First Name : Glenn
Middle Name :
Last Name : Rosen
Position :
University : Stanford University
Proposal Title : "Analysis of Novel Functions of Human Telomerase RNA in IPF"
Proposal Funder :
Dr. Rosen has been on the faculty of the Stanford University School of Medicine since 1993. He is presently an Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine. Dr. Rosen’s laboratory research focuses on translational studies in pulmonary fibrosis; specifically, his laboratory studies mechanisms involved in the pathogenesis of pulmonary fibrosis, and then applies the application of these discoveries to the development of novel treatments for fibrotic lung disease. Recent work in his laboratory has revealed novel functions of telomerase in pulmonary fibrosis and additional studies are focused on the genetics of pulmonary fibrosis. He has published broadly, he is active in clinical trials in idiopathic pulmonary fibrosis and works with biotechnology companies in the development of novel anti-fibrotic therapeutics. Dr. Rosen is the Clinical Director of the Stanford Interstitial Lung Disease Program at the Center for Advanced Lung Disease. Dr. Rosen’s active clinical and research program in interstitial lung disease gives him insight into how to apply basic research discoveries to help patients with advanced lung disease.
Load more comments
Comment by from